Request feasibility assessment
Minimize your project delivery risks through a feasibility assessment. Complete the form below indicating your Real-World Evidence needs for our team of clinical and data experts to assess patient counts and data completeness within our hospital network.
Where You Can Find Us
Health Tech Forward 2025
On 3 December, Dries will be joining the panel on the "European Health Data Space (EHDS): collaboration and partnerships for successful implementation" at Health Tech Forward in Barcelona.
ESMO AI & Digital Oncology 2025
Meet us at ESMO AI & Digital Oncology 2025, where we will be presenting our poster and be giving a mini oral presentation!
ISPOR Europe 2025
Meet us at ISPOR Europe 2025 this November as we join the global conversation on real-world evidence and health economics. Book a meeting now!
ESMO 2025
We'll be at ESMO 2025 in Berlin! Don't miss out on our poster: "Comprehensive characterization of evolving immune checkpoint inhibitor (ICI) indications and outcomes through automated standardization of multicenter EHR data"
OHDSI Europe 2025
We are thrilled to announce our participation as a Gold Sponsor at the 2025 OHDSI Europe Symposium, taking place from July 5-7. This year, the symposium makes its debut outside its usual Rotterdam setting, in the historic "Old Prison" building of Hasselt University, Belgium. We look forward engaging with fellow health tech innovators, hospitals, and life sciences organizations to shape the future of health data science.
European Lung Cancer Congress 2025
On 26 March, at the European Lung Cancer Congress, Dr. Decoster (UZ Brussels) will be presenting the joint poster "Real-World Biomarker Testing and Treatment Patterns in Belgian Lung Cancer Patients: Insights from the AIBED Study".
Belgian Society of Molecular Oncology 2025 Congress
On January 31st, at the BSMO 2025 Congress, Dr. Nuytemans (AZ Groeninge) unveiled the insights from a Belgian multi-center real-world study in breast cancer patients.
ISPOR Europe 2024
We will be attending ISPOR Europe 2024 in Barcelona. Meet our dream team at booth 1126, and discover real-world data use cases in oncology, cardiology and psychiatry, learn more about our European hospital data network and explore the potential of our state-of-the-art proprietary NLP pipeline.
OHDSI Global 2024
We are attending the 10th annual OHDSI Global symposium.
OHDSI UK 2024
We will be attending the OHDSI UK symposium in London!
ESMO 2024
Join us at the ESMO Congress 2024 from 13-17 September in Barcelona, and discover our 2 posters on (i) the real-world usage and adverse events of immune checkpoint inhibitors, and (ii) cardiovascular toxicities in real-world cancer patients treated with immune checkpoint inhibitors.
OHDSI Europe 2024
Meet us at OHDSI Europe 2024 workshops and symposium! On 3 June, Dr. Annelies Verbiest (UZA) and Clara L. Oeste (LynxCare) will provide insights into our Belgian oncology research network and present the initial results from a study into Lung Cancer patients treated with immune checkpoint inhibitors (ICI).
FAQs
Find answers to your questions about our data solutions and services.
A federated approach means data remains at the source hospital under their control. Analysis queries are sent to multiple hospitals, each processes the query locally on their data, and only aggregated results (not patient-level data) are shared back, ensuring privacy and compliance.
5 quality insurance checks from intake to insight (completeness, accuracy, clinical validation, medical review, benchmark match).
Active in Belgium, the Netherlands, France, and Germany, with the ability to extend our European footprint for your research through established collaborations.
